Pioneering the field of drug-device convergence for targeted therapies.
About Us: Scientific Advisors
Michael J. Cima, Ph.D., Massachusetts Institute of Technology
Joseph Grocela, M.D., Massachusetts General Hospital
Robert S. Langer, Ph.D., Massachusetts Institute of Technology
Robert Mayer, M.D., University of Rochester
Robert M. Moldwin, M.D., The Arthur Smith Institute for Urology and Long Island Jewish Medical Center
J. Curtis Nickel, M.D., Queens University
Kenneth Peters, M.D., William Beaumont Hospital
Shahin Tabatabaei, M.D., Massachusetts General Hospital